Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection

被引:7
|
作者
Morena, Diego [1 ,2 ]
Lumbreras, Sara [3 ]
Rodriguez, Jose Miguel [4 ]
Campos, Carolina [1 ]
Castillo, Maria [1 ]
Benavent, Maria [5 ]
Izquierdo, Jose Luis [1 ,6 ]
机构
[1] Hosp Univ Guadalajara, Serv Neumol, Guadalajara, Spain
[2] Univ Alcala, Programa Doctorado Ciencias Salud, Madrid, Spain
[3] Univ Pontificia Comillas IIT, Madrid, Spain
[4] Hosp Univ Principe Asturias, Serv Neumol, Madrid, Spain
[5] SAVANA, Madrid, Spain
[6] Univ Alcala, Dept Med & Especialidades Med, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2023年 / 59卷 / 12期
关键词
Asthma; Chronic obstructive pulmonary disease; Herpes zoster; Lung cancer; Postherpetic neuralgia; Obstructive sleep apnea; Artificial intelligence; CHRONIC MEDICAL CONDITIONS; POSTHERPETIC NEURALGIA; ASTHMA; IMPACT;
D O I
10.1016/j.arbres.2023.08.010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Herpes zoster (HZ) is a condition that results from the reactivation of the varicella zoster virus (VZV). Several diseases have been reported to increase the risk of developing HZ and postherpetic neuralgia (PHN). The objective of this study is to analyze the prevalence and risk factors for HZ and PHN in the most frequent chronic respiratory diseases, which are chronic obstructive pulmonary disease (COPD), asthma, lung cancer and obstructive sleep apnea (OSA).Methods: We conducted an observational, retrospective, non-interventional study between January 2012 and December 2020 based on data from the Castilla-La Mancha Regional Health System in Spain. We used the Savana Manager 3.0 artificial intelligence-enabled system to collect information from electronic medical records.Results: 31 765 subjects presented a diagnosis of HZ. Mean age was 64.5 years (95%CI 64.3-64.7), and 58.2% were women. The prevalence of HZ showed an increasing trend in patients over the age of 50. A risk analysis adjusted for sex and comorbidities in COPD, asthma, lung cancer and OSA presented a higher risk of developing HZ in the first three (OR 1.16 [95%CI 1.13-1.19], 1.67 [1.63-1.71], 1.68 [1.60-1.76], respectively), which further increased in all three when associated with comorbidities. Regarding postherpetic neuralgia, an increased risk was only observed related to COPD and lung cancer (OR 1.24 [95%CI 1.23-1.25], 1.14 [1.13-1.16], respectively), further increasing when associated with comorbidities.Conclusions: In a standard clinical practice setting, the most prevalent respiratory diseases (asthma, COPD and lung cancer) are related to a higher risk of HZ and PHN. These data are fundamental to assess the potential impact of vaccination in this population.(c) 2023 SEPAR. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:797 / 804
页数:8
相关论文
共 50 条
  • [31] Herpes zoster infection
    Bansal, Mohit
    Singh, Sunint
    Arora, Saryu
    Laller, Sanjeev
    Walia, Manpeet
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 5 (06) : 620 - 622
  • [32] Evaluation of the economic burden of Herpes Zoster (HZ) infection A systematic literature review
    Panatto, Donatella
    Bragazzi, Nicola Luigi
    Rizzitelli, Emanuela
    Bonanni, Paolo
    Boccalini, Sara
    Icardi, Giancarlo
    Gasparini, Roberto
    Amicizia, Daniela
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (01) : 245 - 262
  • [33] Is High Altitude a Risk Factor in Development of Herpes Zoster?
    Singh, G. K.
    Deora, Mahendra Singh
    Grewal, Rajan
    Kushwaha, A.
    Minhas, Sukhmeet
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2018, 19 (03) : 244 - 248
  • [34] Risk Factors for Herpes Zoster in Patients with Chronic Kidney Disease: A Case-Control Study
    Li, Zhenxing
    Wang, Qiao
    Ma, Jiahui
    Li, Zhi
    Huang, Dong
    Huang, Yuzhao
    Zhou, Haocheng
    VACCINES, 2021, 9 (09)
  • [35] Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine
    Parameswaran, Ganapathi Iyer
    Wattengel, Bethany A.
    Chua, Hubert C.
    Swiderek, Jessica
    Fuchs, Tom
    Carter, Michael T.
    Goode, Laura
    Doyle, Kathleen
    Mergenhagen, Kari A.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1335 - E1340
  • [36] No Evidence of Family History as a Risk Factor for Herpes Zoster in Patients with Post-Herpetic Neuralgia
    Gatti, A.
    Pica, F.
    Boccia, M. T. Y.
    De Antoni, F.
    Sabato, A. F.
    Volpi, A.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (06) : 1007 - 1011
  • [37] Lifetime risk of herpes zoster in the population of Beijing, China
    Lee, Christa
    Giannelos, Nikolaos
    Curran, Desmond
    Dong, Hengjin
    Tang, Haiwen
    Jiang, Ning
    Ye, Chiyu
    Yuan, Yanfei
    Ng, Cheryl
    PUBLIC HEALTH IN PRACTICE, 2023, 5
  • [38] Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
    Winthrop, Kevin L.
    Melmed, Gil Y.
    Vermeire, Severine
    Long, Millie D.
    Chan, Gary
    Pedersen, Ronald D.
    Lawendy, Nervin
    Thorpe, Andrew J.
    Nduaka, Chudy, I
    Su, Chinyu
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2258 - 2265
  • [39] Herpes zoster as a risk factor for stroke and TIA A retrospective cohort study in the UK
    Breuer, Judith
    Pacou, Maud
    Gauthier, Aline
    Brown, Martin M.
    NEUROLOGY, 2014, 82 (03) : 206 - 212
  • [40] A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China
    Suo, Luodan
    Lu, Li
    Li, Juan
    Sun, Mu
    Wang, Haihong
    Peng, Xinhui
    Yang, Fan
    Pang, Xinghuo
    Marin, Mona
    Wang, Chengbin
    BMC INFECTIOUS DISEASES, 2017, 17